BRIEF-Acrivon Therapeutics, Inc Q1 Income From Operations USD -19.902 Million
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. ACRV | 0.00 |
May 13 (Reuters) - Acrivon Therapeutics, Inc Q1 operating expenses USD 19.902 million.
- Q1 basic EPS USD -0.49
- Q1 net income USD -19.042 million
